Review colorectal cancer screening context from age, family history, and common risk factors. Compares your profile with common screening pathways and discussion points.
This colorectal cancer (CRC) screening worksheet combines age, family history, prior polyp or inflammatory-bowel-disease history, and common lifestyle factors into a simple risk-context summary. It is meant to show how those inputs line up with usual screening conversations, not to function as an official guideline calculator or a stand-alone screening order set.
CRC is one of the most preventable common cancers because screening can detect cancer early and, with colonoscopy, remove many precancerous lesions before they progress. In 2021, the USPSTF lowered the average-risk starting age from 50 to 45 because of rising rates in younger adults.
This page uses a simplified point-and-multiplier model to sort profiles into lower- vs higher-risk screening context. The useful part is the comparison of age and risk factors with the usual screening pathways; the exact percentage should be treated as an educational estimate rather than a validated clinical prediction.
Colorectal screening decisions depend on age, family history, and a few major medical-history factors. This worksheet keeps those inputs together so you can compare average-risk screening with the kinds of situations that usually justify earlier or closer clinician review.
This page uses an educational point-based model rather than an official CRC risk-prediction equation. Base 10-year Risk by Age: <40: 0.1%, 40s: 0.4%, 50s: 0.9%, 60s: 1.5%, 70s: 2.0%, 80+: 2.5% Risk Multiplier = 1 + (Total Risk Points × 0.3) Adjusted Risk = Base Risk × Risk Multiplier × Sex Factor × Race Factor Risk Points: Family history (2), Polyps (2), IBD (3), Smoking (1), Alcohol (1), Obesity (1), Inactivity (1), Processed meat (1), Diabetes (1) Use the output as screening context only. Official screening intervals and start ages come from the underlying guideline sources, not from the point score by itself.
Result: 10-Year Risk: 1.66% — Moderate Risk
At age 55, male, base 10-year risk is 0.9%. Male adjustment increases to ~1.04%. Family history (2 points) + obesity (1 point) = 3 points. Risk multiplier = 1 + 3 × 0.3 = 1.9. Adjusted risk = 1.04% × 1.9 = 1.97%. The page is using that result to flag a higher-risk screening conversation, not to issue a stand-alone interval recommendation.
CRC incidence has been declining overall since the mid-1980s, largely because screening finds and removes many precancerous lesions. However, rates in adults under 50 have risen enough that average-risk screening now begins at 45 instead of 50. That age shift matters more than any single point multiplier on this page.
Colonoscopy visualizes the colon directly and can remove many polyps during the same procedure. FIT is non-invasive and easier to repeat, but it must be done on schedule and followed by colonoscopy when positive. Stool DNA testing, CT colonography, and flexible sigmoidoscopy each fill different roles. This page is mainly trying to place your profile in that screening conversation.
Because the formula here is simplified, the risk number should not be treated as a formal CRC prediction. Family history details, hereditary syndromes, prior adenomas, inflammatory bowel disease, and recent normal colonoscopy findings can matter more than the worksheet percentage itself. Use the result to frame the right screening discussion, not to replace it.
Last updated:
This page does not use an official colorectal-cancer risk equation. Instead, it combines age bands with a simple point-based multiplier for major history and lifestyle factors so the result can sort an average-risk profile from one that deserves earlier or closer screening discussion. The percentage output is an educational estimate; the more important output is the screening-context comparison that follows it.
Official screening start ages, intervals, and high-risk pathways come from the underlying guideline sources. Family history details, prior colonoscopy findings, hereditary syndromes, inflammatory bowel disease, and stool-test follow-up all need clinician review beyond this worksheet.
The USPSTF and ACS recommend screening at age 45 for average-risk adults. People with a strong family history, inflammatory bowel disease, Lynch syndrome, or familial adenomatous polyposis often need earlier or more individualized planning. The exact start age should come from the underlying guideline pathway, not from the point score alone.
They are different tools. Colonoscopy visualizes the colon directly and can remove polyps during the same procedure, while FIT is a stool-based screening test that has to be repeated on schedule and followed by colonoscopy if positive. The best test is usually the screening method a person is willing and able to complete consistently.
Warning signs include blood in stool, persistent change in bowel habits, unexplained weight loss, abdominal cramping, and iron-deficiency anemia. However, early CRC is usually asymptomatic — that's why screening is essential. Don't wait for symptoms to get screened.
Yes. One first-degree relative with CRC doubles your risk; two first-degree relatives increases it 3–4×. If the relative was diagnosed before age 50, your risk increases further. Lynch syndrome (hereditary nonpolyposis CRC) and FAP carry lifetime CRC risks of 50–80% and nearly 100%, respectively.
Cologuard (multi-target stool DNA test, mt-sDNA) is a home stool test that detects both DNA mutations and blood associated with CRC. It has ~92% sensitivity for cancer but a higher false-positive rate (~13%) than FIT. Recommended every 3 years. A positive Cologuard always requires follow-up colonoscopy.
Evidence strongly supports that a diet high in fiber, fruits, vegetables, and whole grains while low in red and processed meat reduces CRC risk by 20–35%. Calcium and vitamin D supplementation may also be protective. The Mediterranean diet pattern is associated with the lowest CRC incidence.